LJI scientists discover how T cells transform to defend our organs
Future drugs could target specialized T cells to help the body fight tumors, infections, and more
Disease Lung Cancer
LJI scientists receive Curebound funding to advance cancer research
Curebound grants may lead to new approaches to fight breast cancer, lung tumors and more
Vijayanand Lab
Pandurangan Vijayanand, M.D., Ph.D., and his lab members employ genomics tools to understand, diagnose and treat pulmonary disease such as asthma, lung cancer and infectious diseases, including the novel coronavirus.
Reina Lab
Dr. Reina-Campos’ lab seeks to understand the underlying principles governing tissue immune networks that enable robust and long-term protection against infection and tumors.
A step toward personalized immunotherapy for all
Scientists find evidence that all cancer patients mount an immune response to their tumors, suggesting that many more patients could benefit from personalized immunotherapy
Investigating cancer drug toxicity leads to a critical discovery
Researchers uncover a new strategy to avoid cancer immunotherapy side effects
Many cancer patients may need a sequential one-two punch of immunotherapies
Treating patients with anti-CTLA4 therapies prior to anti-PD1 treatment may be a promising strategy